GO
Loading...

Merck CFO to Retire in July

Merck said Chief Financial Officer Judy Lewent, 58, plans to retire in July after 17 years in the post.

The drugmaker, which has seen its fortunes greatly improve over the past two years in the aftermath of the 2004 withdrawal of the company's blockbuster Vioxx arthritis drug, said Lewent has played a leading role in the "resurgence of Merck's corporate development" and licensing of drugs from other drugmakers.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

Don't Miss

U.S. Video

  • CNBC's Meg Tirrell, has the latest details on the White House summit with medical researchers.

  • The downward spiral in oil has produced gains in consumers' wallets. Could the dip in energy rob the market of future growth? S&P Capital IQ Equity Chief Investment Officer Erin Gibbs and BlackRock CIO of Fundamental Fixed Income Rick Rieder discuss ways to find yield.

  • The FMHR traders have the play on Amazon's big profit, as the company grows it Prime space.